1. Global measles and rubella strategic plan 2012–2020;World Health Organization,2012
2. Global vaccine action plan: 2011–2020;World Health Organization,2013
3. Dimech W, Mulders MN. A 16-year review of seroprevalence studies on measles and rubella and other vaccine preventable diseases [submitted for publication].
4. The 2001 serological survey in the Czech Republic–measles;Mrazova;Cent Eur J Public Health,2003
5. The seroprevalence of IgG antibodies against rubella (German measles) in 10–49 year-old women from Cartagena, Colombia;Mora-Garcia;Rev Salud Publica (Bogota),2011